Does AMLODIPINE Cause Salivary hypersecretion? 37 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 37 reports of Salivary hypersecretion have been filed in association with AMLODIPINE (Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide). This represents 0.1% of all adverse event reports for AMLODIPINE.
37
Reports of Salivary hypersecretion with AMLODIPINE
0.1%
of all AMLODIPINE reports
4
Deaths
13
Hospitalizations
How Dangerous Is Salivary hypersecretion From AMLODIPINE?
Of the 37 reports, 4 (10.8%) resulted in death, 13 (35.1%) required hospitalization, and 1 (2.7%) were considered life-threatening.
Is Salivary hypersecretion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMLODIPINE. However, 37 reports have been filed with the FAERS database.
What Other Side Effects Does AMLODIPINE Cause?
Hypotension (6,504)
Toxicity to various agents (5,554)
Completed suicide (5,267)
Drug ineffective (4,091)
Dyspnoea (3,907)
Dizziness (3,536)
Intentional overdose (3,427)
Fall (3,215)
Fatigue (3,141)
Headache (2,907)
What Other Drugs Cause Salivary hypersecretion?
CLOZAPINE (1,349)
ARIPIPRAZOLE (497)
RISPERIDONE (485)
OLANZAPINE (449)
QUETIAPINE (299)
CARBIDOPA\LEVODOPA (248)
HALOPERIDOL (216)
DIAZEPAM (185)
CLONAZEPAM (179)
LORAZEPAM (165)
Which AMLODIPINE Alternatives Have Lower Salivary hypersecretion Risk?
AMLODIPINE vs AMLODIPINE BESILATE
AMLODIPINE vs AMLODIPINE\ATORVASTATIN
AMLODIPINE vs AMLODIPINE\BENAZEPRIL
AMLODIPINE vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN
AMLODIPINE vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL